We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
-9.53%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$8.52B
AUM Growth
-$320M
Cap. Flow
+$757M
Cap. Flow %
8.89%
Top 10 Hldgs %
11.37%
Holding
608
New
127
Increased
223
Reduced
94
Closed
151

Top Buys

Rank Stock Value
1
SUNE
SUNEDISON, INC COM
SUNE
+$106M
2
BCR
CR Bard Inc.
BCR
+$102M
3
CTSH icon
Cognizant
CTSH
+$100M
4
MSFT icon
Microsoft
MSFT
+$93.4M
5
BDX icon
Becton Dickinson
BDX
+$92.6M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$73.3M
2
HPQ icon
HP
HPQ
+$72.4M
3
ATVI
Activision Blizzard
ATVI
+$69.4M
4
DTV
DIRECTV COM STK (DE)
DTV
+$61.8M
5
ZBH icon
Zimmer Biomet
ZBH
+$57.9M

Sector Composition

Rank Sector Weight
1 Industrials 17.99%
2 Financials 14.52%
3 Technology 14.34%
4 Healthcare 13.66%
5 Energy 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADMA icon
426
ADMA Biologics
ADMA
$2.22B
$468K 0.01%
55,943
+5,120
+10% +$47.3K
TCPI
427
DELISTED
TCP International Hldgs Ltd.
TCPI
$422K 0.01%
153,287
+14,029
+10% +$50.2K
MBII
428
DELISTED
Marrone Bio Innovations, Inc.
MBII
$418K ﹤0.01%
197,881
+13,844
+8% +$27K
CHRD icon
429
Chord Energy
CHRD
$7.39B
$417K ﹤0.01%
48,031
-1,601,727
-97% -$16.8M
WD icon
430
Walker & Dunlop
WD
$1.53B
$400K ﹤0.01%
15,347
-119,302
-89% -$2.98M
KALV
431
DELISTED
KalVista Pharmaceuticals
KALV
$390K ﹤0.01%
7,803
+670
+9% +$57.1K
INVE icon
432
Identive
INVE
$61.9M
$370K ﹤0.01%
106,085
-58,483
-36% -$259K
EGLT
433
DELISTED
Egalet Corporation
EGLT
$363K ﹤0.01%
+27,518
New +$349K
AXAS
434
DELISTED
Abraxas Petroleum Corp
AXAS
$358K ﹤0.01%
13,986
+1,280
+10% +$47.6K
CYTK icon
435
CALL
Cytokinetics
CYTK
$10.4B
$339K ﹤0.01%
50,607
– –
ATXS
436
DELISTED
Astria Therapeutics
ATXS
$325K ﹤0.01%
670
-163
-20% -$116K
ROKA
437
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
$324K ﹤0.01%
16,599
+1,353
+9% +$37.4K
BIOA
438
DELISTED
BioAmber Inc.
BIOA
$303K ﹤0.01%
56,706
-55,337
-49% -$365K
TRIL
439
DELISTED
Trillium Therapeutics Inc.
TRIL
$292K ﹤0.01%
22,378
+2,049
+10% +$37.7K
CYTK icon
440
Cytokinetics
CYTK
$10.4B
$271K ﹤0.01%
40,485
– –
APIC
441
DELISTED
Apigee Corporation Common Stock
APIC
$259K ﹤0.01%
24,544
+9,297
+61% +$80.6K
CEMP
442
DELISTED
Cempra, Inc.
CEMP
$256K ﹤0.01%
+9,201
New +$342K
OEC icon
443
Orion
OEC
$409M
$241K ﹤0.01%
+16,700
New +$287K
QTNT
444
DELISTED
Quotient Limited Ordinary Shares
QTNT
$234K ﹤0.01%
450
-583
-56% -$364K
LINC icon
445
Lincoln Educational Services
LINC
$1.3B
$226K ﹤0.01%
442,633
+228,598
+107% +$235K
XNCR icon
446
Xencor
XNCR
$1.55B
$200K ﹤0.01%
16,317
-194,187
-92% -$3.8M
CBIO
447
Crescent Biopharma
CBIO
$626M
$196K ﹤0.01%
350
+32
+10% +$23.1K
ALTA
448
DELISTED
Altabancorp
ALTA
$186K ﹤0.01%
11,388
-28,612
-72% -$485K
IVTY
449
DELISTED
Invuity, Inc
IVTY
$186K ﹤0.01%
13,268
+917
+7% +$12K
TLOG
450
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
$171K ﹤0.01%
92,225
+8,439
+10% +$20.1K
16 17
18
19 20

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q3 2015 Portfolio in Review

As of Q3 2015, Alyeska Investment Group held 608 positions worth $8.52B, down 3.6% from $8.84B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Alyeska Investment Group deployed $757M of net new capital in Q3 2015, opening 127 new positions and adding to 223 existing holdings. Its largest new stake was SUNEDISON, INC COM: 5,924,743 shares worth $42.5M.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 14% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was HP, an estimated $72.4M trimmed.

  • Alyeska Investment Group's largest Q3 2015 buy was SUNEDISON, INC COM: 5,924,743 shares worth $42.5M.
  • Alyeska Investment Group added most to NorthStar Realty Finance Corp. in Q3 2015, an estimated $75.1M increase.
  • Alyeska Investment Group's biggest Q3 2015 reduction was HP, cutting an estimated $72.4M.
  • Alyeska Investment Group fully exited Cigna in Q3 2015, selling an estimated $73.3M.
  • Alyeska Investment Group's ten largest holdings make up 11% of its $8.52B portfolio in Q3 2015.
  • Alyeska Investment Group opened 127 new positions and closed 151 in Q3 2015.
  • Alyeska Investment Group's portfolio value fell 3.6% quarter-over-quarter to $8.52B.

Based on Alyeska Investment Group's 13F filing for Q3 2015, filed 16 Nov 2015.